This website uses cookies to ensure you get the best experience on our website. Details can be found in our Privacy Policy. By clicking the "Accept” button, closing this banner, or continuing to use our website, you agree to our Privacy Policy.
Privacy Policy
OPN Healthcare
  • Company
    • The OPN Story
    • Mission & Focus
    • OPN Leadership
    • Latest News
  • Platform
    • Value-Based Networks
    • Care Management Services
    • Data Analytics
    • Clinical Trials
  • Alignment
    • Overview
    • Provider Resources
    • Payer Advantages
    • Patient Support
    • Partners
  • Oncologists
    • Overview
    • Case Studies
  • Risk-Holders
    • Overview
    • Case Studies
  • Search OPN
  • Company
    The OPN StoryMission & FocusOPN LeadershipLatest News
  • Platform
    Value-Based NetworksCare Management ServicesData AnalyticsClinical TrialsActive Clinical Trials
  • Alignment
    OverviewProvider ResourcesPayer AdvantagesPatient SupportPartners
  • Oncologists
    OverviewCase Studies
  • Risk-Holders
    OverviewCase Studies
  • Contact Us
  • Privacy Policy
  • Terms & Conditions
  • Company
    • The OPN Story
    • Mission & Focus
    • OPN Leadership
    • Latest News
  • Platform
    • Value-Based Networks
    • Care Management Services
    • Data Analytics
    • Clinical Trials
  • Alignment
    • Overview
    • Provider Resources
    • Payer Advantages
    • Patient Support
    • Partners
  • Oncologists
    • Overview
    • Case Studies
  • Risk-Holders
    • Overview
    • Case Studies
  • Search OPN

Latest News

Quarterly Insights

Alternative Regimens: Additional Guideline Considerations

Regimen review in addition to National Comprehensive Cancer Network (NCCN) guideline compliance can fine-tune cancer treatments for improved outcomes, reduced toxicity and cost.

Quarterly Insights

Alternative Regimens: Additional Guideline Considerations

Quarterly Insights

Value-Based Oncology and the Role of Digital Health

Clinical Trials

Breakthrough Status for Dizal’s Sunvozertinib

Clinical Trials

Breakthrough Status for Dizal’s Sunvozertinib

OPN’s Chief Medical Officer Anthony Lam will Lead a New Lung Cancer Clinical Trial

Study Recruitment for OPN Managed Clinical Trial

Read More Clinical Trials

OPN Updates

OPN’s Partnership with Kaid Health Expands Provider Support

OPN Presents at the Transitions 2022 APG Colloquium

OPN is Presenting at the 2022 APG Midwest Regional Meeting

Read More OPN Updates

Quarterly Insights

Alternative Regimens: Additional Guideline Considerations

Value-Based Oncology and the Role of Digital Health

Managing Supportive Care in Value-Based Oncology

Read More Quarterly Insights

Technology

OPN’s Partnership with Kaid Health Expands Provider Support

Study Recruitment for OPN Managed Clinical Trial

OPN Healthcare Debuts Care Management Services

Read More Technology
OPN Logo
  • Company
  • Platform
  • Alignment
  • Oncologists
  • Risk-Holders
  • Contact Us
  • OPN Healthcare, Inc.
    550 N Brand Blvd., Suite 1000
    Glendale, CA 91203
  • info@opnhc.com
  • Phone: (818) 507-4732
OPN Healthcare © 2025. All Rights Reserved.